Dare Bioscience, Inc. — Director's Dealing 2016

Jan 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2016-01-04

Reporting Person: WALT DAVID R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-04	Common Stock	P	4500	$3.0051	Acquired	31991	Direct
2016-01-05	Common Stock	P	4301	$3.0616	Acquired	36292	Direct

Footnotes

F1: Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $2.91 to $3.07 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.

F2: Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $2.98 to $3.09 per share. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.